May 2019 Vol. 7 No.5

Abstract
• Full text
•Reprint (PDF) (136 KB)

Search Pubmed for articles by:
 

Review

HPV Vaccines: Effectiveness and Adverse Effects

Ioannis Thanasas^1*, Giagkos Lavranos², Pinelopi Gogou³ and Dimitrios Paraskevis⁴

¹Department of Obstetrics & Gynecology of General Hospital in Trikala, Trikala, Greece
²Medical School and Department of Health Sciences, European University Cyprus, Cyprus
³Clinical Oncology Department, Norwich University Hospital, UK
⁴Department of Hygiene Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece

*Corresponding Author’s E-mail: thanasasg@hotmail.com
Tel.: 00302431029103 / 00306944766469

Accepted May 07, 2019

Abstract

Preventive vaccination against human papillomavirus is the new practice in the treatment of cervical cancer. The successful vaccination programs include the use of three vaccines, capable of causing neutralization of antibodies from the virus particles, together with their envelope: the bivalent, quadrivalent and ninevalent HPV vaccines. Following administration of the vaccines, the immune system is being stimulated, producing antibodies to the HPV particles that protect against infection and disease. The safety profile of licensed HPV vaccines based on clinical and post-marketing data is reassuring.

Keywords: Vaccination, Human Papillomavirus, safety, recommendations.